facebook

Dalal & Broacha Long Term Growth

Scheme Rating

IME Scheme Rating

The Scheme does not meet our selection criteria at this time

Can be considered for Investing: We even as we prefer other Flexi-cap strategies, with more defined investment philosophies & consistency of performance.

IME Strategy Rating

Strategy Definition not as tight as our preferences: Long-term growth strategy to invest in companies and sectors that can reap the maximum benefits arising out of the India growth story driven by demographic dividends and increasing per capita income. But the strategy is not tightly defined, which does have it’s pros & cons. While a loosely defined strategy does allow the fund manager the flexibility to change portfolio positioning based on the market environment, we prefer greater clarity on how the portfolios are likely to be constructed.

PMS Scheme Ratings are driven by IME’s Proprietary Scheme Rating Methodology, which takes into account our ratings of the Scheme’s investment strategy, its maturity, the investment team, and our separate rating on the AMC that runs this particular scheme. Our views on each of these individual criteria are available via the IME RMS – which you can view by reaching out to one of our relationship managers (using either the live chat or book appointment feature on this site).

IME View on Dalal & Broacha Long Term Growth

Type: Flexi Cap | GARP | AUM (661.2 cr) | Inc Date (24 Aug 2007)

Dala & Broacha Long Term Growth- Investment Strategy

Focus on companies benefiting from India Growth story

Dalal & Broacha PMS’s Long Term Growth strategy aims to invest in companies that can benefit the most out of the India Growth story (demographic dividend, rising per-capita income). The aim is to invest in good businesses, with decent managements that are available at reasonable prices.

Trailing Performance

1yr 3yr 5yr Since Inception
Dalal & Broacha Long Term Growth 52.3 17.6 19.1 14.1
S&P BSE 500 TRI 39.5 19.5 19 10.6
Alpha over Broad Mkt BM 12.8 -1.9 0.1 3.5
Nifty 500 38.4 18.1 17.5
Alpha over Category BM 13.9 -0.5 1.6

Performance as of: 28-Feb-23 | Inception Date: 24-Aug-07

Fund Managers

Milind Karmarkar | 4-star rated FM

Fund Manager | 27 yrs Experience | 16 yrs at current firm

Past Experience: Dalal & Broacha (Head-Equity & Head-Research)

Milind is a seasoned investment professional and long-time vetran at Dalal & Broacha. At Dalal & Broacha, he has been the Head of Research (1997-2002) and Head of Equity (2002-2007), prior to taking charge of fund management of the PMS in Oct-2007.

Nawaz Sarfaraz | 2-star rated FM

Asst Fund Manager | 16 yrs Experience | 5 yrs at current firm

Past Experience: IDBI AMC (Head-Resarch), Arihant Capital (Analyst), Dimensional (Analyst)

Nawaz assists Milind in managing the PMS portfolios at Dalal & Broacha. He has close to a decade’s experience in equity research, spread across the buy-side (IDBI AMC) and the sell-side (Arihant, Dimensional).

Fee Structure

Fee StructureFee
Fixed Fee Structure2
Variable Fee Structures
Exit Fees

AMC

AMC: Dalal & Broacha PMS (click link for detailed AMC review)

Not a top recommendation due to lack of differentiation : While we like the broking heritage of the Dalal & Broacha group and the long tenure of their PMS Head, a lack of a clearly defined investment philosophy and weak differentiation makes us prefer other PMS providers.

AMC Rating

3 of 5 stars

AMC Pedigree

2 of 5 stars

AMC Size

3 of 5 stars

Team Pedigree

3 of 5 stars

Inv Philosophy

1 of 5 stars

Performance

3 of 5 stars

Get substantially greater insights by connecting with us!

Details shared on the public website, are only a short snapshot of the more detailed analysis that resides in our Proprietary Research Management Solution (RMS) – A proprietary cloud-based tool, that ensures that the unbiased research insights of our central research team are shared directly with investors.

Our RMS allows us to operate with a level of transparency, ethics & consistency of insights, that is unparrarelled in the industry. Our RM’s will help showcase the PMS/AIF options that are the most suited for your unique requirements.

Download Sample RMS Reports: AMC View | Scheme Comparison

Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.